A computer‐based model to assess costs associated with the use of factor VIII and factor IX one‐stage and chromogenic activity assays

This publication has 20 references indexed in Scilit:

• Development of long-acting recombinant FVIII and FIX Fc fusion proteins for the management of hemophilia
  Expert Opinion on Biological Therapy, 2013
• Survey of laboratory tests used in the diagnosis and evaluation of haemophilia A
  Thrombosis and Haemostasis, 2013
• Diagnosis and treatment of factor VIII and IX inhibitors in congenital haemophilia: (4th edition)
  British Journal of Haematology, 2012
• Standards and monitoring treatment
  Haemophilia, 2012
• International comparative field study of N8 evaluating factor VIII assay performance
  Haemophilia, 2011
• The responsiveness of different APTT reagents to mild factor VIII, IX and XI deficiencies
  International Journal of Laboratory Hematology, 2010
• Influence of source of phospholipids for APTT‐based factor IX assays and potential consequences for the diagnosis of mild haemophilia B
  Haemophilia, 2009
• Discrepant factor VIII activity in a family with mild haemophilia A and^Arg531^Hismutation using various FVIII assays and APTT reagents
  Haemophilia, 2005
• Coagulation and Chromogenic Assays of Factor VIII Activity: General Aspects, Standardization, and Recommendations
  Seminars in Thrombosis and Hemostasis, 2002
• Assaying the Circulating Factor VIII Activity in Hemophilia A Patients Treated with Recombinant Factor VIII Products
  Seminars in Thrombosis and Hemostasis, 2002